Find clinical trials for Triple Negative Breast Cancer in Hanyang, Seoul

of durvalumab in combination with novel oncology therapies with or without paclitaxel and durvalumab + paclitaxel for first-line metastatic triple...

(SG) given at an alternative dose and schedule, in participants with triple-negative breast cancer (TNBC).The pri...

and capecitabine) for the treatment of first-line metastatic triple-negative breast cancer (TNBC) or estrogen rec...

previously untreated, locally advanced, inoperable or metastatic triple-negative breast cancer whose tumors...

for patients with previously untreated, locally advanced, unresectable or metastatic (Stage IV) programmed death-ligand 1 (PD-L1)-positive triple...

This is a Phase III, randomised, open-label, 2 arm, multicentre, international study assessing the efficacy and safety of Dato-DXd compared with ICC...

after induction with first-line chemotherapy plus pembrolizumab in triple negative breast cancer (TNBC). The prim...

with previously untreated, locally advanced inoperable or metastatic triple-negative breast cancer, whose tumors...

with stage I to III TNBC with residual invasive disease in the breast and/or axillary lymph nodes at surgical resection following neoadjuvan...

vs placebo as adjuvant therapy in participants who have triple negative breast cancer (TNBC).After a screening ph...